Oxygen Biotherapeutics to Host Shareholder Presentation and Present at the 10th Annual Biotech Forum in Zurich, Switzerland
September 09, 2010 18:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company will host a presentation to shareholders on...
Oxygen Biotherapeutics TBI Study to be Offered to Injured Israeli Soldiers
September 07, 2010 20:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
Oxygen Biotherapeutics Announces First Quarter FY2011 Financial Results Conference Call and Webcast
September 03, 2010 18:52 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
Oxygen Biotherapeutics to Present at Rodman & Renshaw Conference in New York
September 01, 2010 09:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the company will present at the Rodman & Renshaw Annual Global...
Study Shows DERMACYTE(R) Oxygen Concentrate Appears to Improve the Appearance of Fine Lines and the Perception of Skin Appearance
August 31, 2010 08:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Aug. 31, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that results from an 8-week cosmetic study showed that the topical...
Photo Release -- DERMACYTE(R) Oxygen Concentrate Now Available in 10ml Pump Bottles
August 03, 2010 07:50 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Aug. 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company now offers its revolutionary anti-aging,...
Oxygen Biotherapeutics Signs CRADA With U.S. Navy to Study Treatment of Decompression Sickness Using Oxycyte(R) Emulsion
August 02, 2010 12:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has entered into a Cooperative Research and Development Agreement...
Photo Release -- Oxygen Biotherapeutics Introduces DERMACYTE(R) Oxygenating Eye Complex, an Oxygen-Rich Serum to Reduce the Appearance of Fine Lines Around Eyes
July 28, 2010 20:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., July 28, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today introduced its new, innovative skin care product, DERMACYTE® Oxygenating...
Oxygen Biotherapeutics Files FY2010 Annual Report on Form 10-K
July 23, 2010 16:38 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., July 23, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission (SEC)...
Oxycyte(R) PFCE Decreases Mortality From Decompression Sickness in Preclinical Study
June 30, 2010 11:33 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., June 30, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that results from U.S. Navy studies demonstrated decreased mortality in porcine animal models...